Hims & Hers Health Inc. buy Guggenheim
Start price
28.02.23
/
50%
€11.00
Target price
28.02.24
€14.12
Performance (%)
12.73%
End price
29.02.24
€12.40
Summary
This prediction ended on 29.02.24 with a price of €12.40. The prediction had a final performance of 12.73%. Guggenheim has a follow-up prediction for Hims & Hers Health Inc. where he still thinks Hims & Hers Health Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Hims & Hers Health Inc. | -2.330% | -2.330% | 101.786% |
iShares Core DAX® | -1.414% | 7.218% | 17.151% |
iShares Nasdaq 100 | -2.316% | 4.450% | 18.360% |
iShares Nikkei 225® | -2.756% | 10.071% | 10.704% |
iShares S&P 500 | -1.849% | 4.760% | 19.639% |
Comments by Guggenheim for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $15.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
In the thread Trading Hims & Hers Health Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€12.65
27.02.24
27.02.24
€15.66
27.02.25
27.02.25
1.23%
11:15
11:15